Mexitil, a new anti-arrhythmia agent
Heinrich, K.
Medizinische Klinik 75(6): 235-237
1980
ISSN/ISBN: 0025-8458 PMID: 7393119 Document Number: 165762
Document emailed within 1 workday
Related Documents
Kipshidze, N.N.; Chapidze, G.E.; Dzhandzhgava, S.M. 1980: Clinical study of the anti-arrhythmia preparation, mexitil Kardiologiia 20(10): 100-102Giec, L. 1985: Amiodarone as an anti-arrhythmia agent Kardiologia Polska 28(1): 1-9
Steinbeck, G. 1991: Which anti-arrhythmia agent in continuous ventricular tachycardia? Medizinische Klinik 86(12): 659-660
Garimoldi, M.; Pirastu, A.; Barbanotti, G.; Sghirinzetti, M.; Catalano, M.; Castelfranco, M. 1988: Treatment of ventricular arrhythmia with mexiletine (Mexitil), monitored by Holter ambulatory electrocardiography Minerva Cardioangiologica 36(4): 159-165
Sokolov, S.F.; Golitsyn, S.P.; Malakhov, V.I.; Bankuzov, V.A.; Koltunova, M.I.; Golitsyn, L.S. 1990: The anti-arrhythmia activity and effect on the heart conduction system of the new anti-arrhythmia preparation bonnecor Farmakologiia i Toksikologiia 53(3): 57-60
Tuna, J.L. 1992: Classification of anti-arrhythmia drugs and their mechanism of action. Iatrogeny of anti-arrhythmia agents Revista Portuguesa de Cardiologia: Orgao Oficial da Sociedade Portuguesa de Cardiologia 11(4): 385-386
Zil'berter, I.I.; Khodorov, B.I.; Shubert, B. 1983: Stimulus-dependent blockade of the Na channels of isolated myocardial cells in the rat by the anti-arrhythmia agent N-propyl ajmaline (neogiluritmal) Biulleten' Eksperimental'noi Biologii i Meditsiny 95(4): 55-58
Storozhuk, B.G. 1985: Anti-arrhythmia activity and side effects of various anti-arrhythmia agents Vrachebnoe Delo 3: 41-44
Leclercq, J.F.; Attuel, P.; Milosevic, D.; Coumel, P. 1979: Quantitative evaluation of the efficacy of anti-arrhythmia agents in chronic ventricular arrhythmia Acta Cardiologica 34(1): 35-50
Nakamura, H. 2004: Recent progress in molecular etiology of arrhythmia and anti-arrhythmia drug therapy Masui. Japanese Journal of Anesthesiology 53 Suppl: S81-S90
Bracchetti, D.; Mantovani, B.; Naccarella, F.; Lombardi, G.; Palmieri, M. 1980: Evaluation of the efficacy of anti-arrhythmia agents in hyperkinetic ventricular arrhythmia Bollettino Della Societa Italiana di Cardiologia Suppl: 117-123
Savina, M.D.; Kudrin, A.N. 1982: Anti-arrhythmia activity of fusaric acid N,N-diethylaminoethylamide in experimental arrhythmia models in comparison with novocainamide Farmakologiia i Toksikologiia 45(2): 63-65
Bonhorst, D. 1992: Choice of anti-arrhythmia agents: the arrhythmia-patient binomial Revista Portuguesa de Cardiologia: Orgao Oficial da Sociedade Portuguesa de Cardiologia 11(4): 387-389
Mazur, N.A.; Kurbanov, R.D. 1984: Deterioration in ventricular arrhythmia caused by anti-arrhythmia preparations Terapevticheskii Arkhiv 56(9): 67-70
Lishmanov, I.B.; Maslov, L.N.; Krylatov, A.V.; Ugdyzhekova, D.S.; Gilligan, P.; Tam, S.W. 2000: The anti-arrhythmia and pro-arrhythmia properties of sigma-receptor ligands Eksperimental'naia i Klinicheskaia Farmakologiia 63(2): 39-43
Hohnloser, S.H.; Meinertz, T.; Mehender, M.; Geibel, A.; Just, H. 1988: Induction and increase of cardiac arrhythmia by anti-arrhythmia agents Der Internist 29(5): 338-344
Lumholtz, I.B. 1981: Drug information: agents for the treatment of arrhythmias. Therapeutic main group: anti-arrhythmia agents. 16. (3). Anti-arrhythmia agents with action on ventricular arrhythmias Sygeplejersken 81(2): 15
Smetnev, A.S.; Golitsyn, S.P.; Levin, E.R.; Sokolov, S.F.; Koltunova, M.I. 1988: Study of the comparative anti-arrhythmic effectiveness of allapinin, ethacizine and mexitil in patients with ventricular disorders of cardiac rhythm Terapevticheskii Arkhiv 60(8): 34-38
Sun, Y.; Fang, M.; Davies, H.; Hu, Z. 2014: Mifepristone: a potential clinical agent based on its anti-progesterone and anti-glucocorticoid properties Gynecological Endocrinology: the Official Journal of the International Society of Gynecological Endocrinology 30(3): 169-173
De Arcangelis, A. 1971: On the use in anti-rheumatic therapy of a new non-steroid anti-inflammatory agent: glucosamide of monohydrated (N-p-chloro-benzoyl-2-methyl-5-methoxy)-indol-3-acetic acid La Clinica Terapeutica 59(3): 229-239